pembrolizumab
Showing 1 - 25 of 1,067
Cancer Trial in Villejuif (Pembrolizumab, Pembrolizumab and Olaparib, Pembrolizumab adjuvant)
Not yet recruiting
- Cancer
- Pembrolizumab
- +2 more
-
Villejuif, Val De Marne, FranceGustave Roussy
Oct 30, 2023
MSI-H Colorectal Cancer Trial in Pittsburgh (Regorafenib, Pembrolizumab)
Not yet recruiting
- MSI-H Colorectal Cancer
- Regorafenib
- Pembrolizumab
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Aug 17, 2023
Solid Tumor, Cutaneous Squamous Cell Carcinoma, Endometrial Cancer Trial (favezelimab/pembrolizumab, pembrolizumab, lenvatinib)
Not yet recruiting
- Solid Tumor
- +2 more
- favezelimab/pembrolizumab
- +2 more
- (no location specified)
Sep 7, 2023
Sinonasal Undifferentiated Carcinoma Trial in Pavia (Pembrolizumab)
Not yet recruiting
- Sinonasal Undifferentiated Carcinoma
- Pembrolizumab
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri
Jun 21, 2023
Head and Neck Squamous Cell Carcinoma Trial (Zanzalintinib, Zanzalintinib-matched Placebo, Pembrolizumab)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Zanzalintinib
- +2 more
- (no location specified)
Oct 9, 2023
Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)
Not yet recruiting
- Metastatic Melanoma
- Head and Neck Squamous Cell Carcinoma
- GB1211
- +2 more
-
Portland, OregonProvidence Portland Medical Center
Jun 19, 2023
Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)
Not yet recruiting
- Differentiated Thyroid Cancer
- Pembrolizumab
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri
May 5, 2023
Stage IIIA NSCLC Trial in Cleveland (Cisplatin, Etoposide, Pembrolizumab)
Terminated
- Stage IIIA Non-Small Cell Lung Cancer
- Cisplatin
- +3 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Dec 15, 2022
Hodgkin Lymphoma Trial in Cologne (Pembrolizumab)
Not yet recruiting
- Hodgkin Lymphoma
- Pembrolizumab
-
Cologne, Germany1st Department of Medicine, Cologne University Hospital
Sep 19, 2023
Metastatic NSCLC Trial (Pembrolizumab coformulated with hyaluronidase, Pemetrexed, Cisplatin)
Not yet recruiting
- Metastatic Non-small Cell Lung Cancer
- Pembrolizumab coformulated with hyaluronidase
- +6 more
- (no location specified)
Jan 27, 2023
Lung Cancer Trial (Sacituzumab Govitecan, Pembrolizumab)
Not yet recruiting
- Lung Cancer
- Sacituzumab Govitecan
- Pembrolizumab
- (no location specified)
Sep 20, 2023
Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint
Not yet recruiting
- Recurrent Head and Neck Cancer
- +5 more
- Ramucirumab
- Pembrolizumab
-
Saint Louis, MissouriWashington University School of Medicine
Jul 30, 2023
Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)
Not yet recruiting
- Pancreatic Cancer
- Gemcitabine
- +2 more
-
Baltimore, MarylandSKCCC Johns Hopkins
Aug 16, 2023
Advanced Solid Tumors Trial (AMG 355, Pembrolizumab)
Not yet recruiting
- Advanced Solid Tumors
- AMG 355
- Pembrolizumab
- (no location specified)
Nov 9, 2023
NSCLC, Melanoma Trial (IMM60, Pembrolizumab)
Not yet recruiting
- Non-small Cell Lung Cancer
- Melanoma
- IMM60
- Pembrolizumab
- (no location specified)
Jan 24, 2023
Cholangiocarcinoma Trial in Houston (Pembrolizumab, Gemcitabine, Cisplatin)
Not yet recruiting
- Cholangiocarcinoma
- Pembrolizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 21, 2023
Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (Tazemetostat, Pembrolizumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Tazemetostat
- Pembrolizumab
-
Saint Louis, MissouriWashington University School of Medicine
Oct 26, 2022
Colorectal Cancer Trial (Pembrolizumab)
Recruiting
- Colorectal Cancer
- Pembrolizumab
-
Amsterdam, NetherlandsNetherlands Cancer Institute
Jan 3, 2023
Urothelial Carcinoma Trial in New York (Naptumomab Estafenatox, Pembrolizumab, Obinutuzumab)
Not yet recruiting
- Urothelial Carcinoma
- Naptumomab Estafenatox
- +2 more
-
New York, New YorkWeill Cornell Medicine/NewYork-Presbyterian Hospital
May 30, 2023
Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy, Pembrolizumab Trial in Beijing (Pembrolizumab, Cisplatin,
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +2 more
- Pembrolizumab
- +7 more
-
Beijing, Beijing, ChinaBeijing Tongren Hospital
Oct 26, 2023
GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)
Recruiting
- GastroEsophageal Cancer
- Gastric Cancer
- Neratinib
- +4 more
-
Tampa, FloridaMoffitt Cancer Center
Oct 25, 2023
Locally Advanced Esophageal and Gastric Cancers (EGC) Trial in Durham (Pembrolizumab)
Active, not recruiting
- Locally Advanced Esophageal and Gastric Cancers (EGC)
- Pembrolizumab
-
Durham, North CarolinaDuke Cancer Center
Dec 7, 2022